Replies to post #24114 on RespireRx Pharmaceuticals Inc (fka RSPI)

[gfp927z]

Enemem, >>> Which prospective partners are still viable? <<<

That's what I'd like to know also. Neuro said the pain oriented mid-caps like Endo, Cephalon, and Purdue were all going in other directions, away from pain. I suppose that leaves us with 'Reckitt Benckiser'.

[tonyvanw]

<Which prospective partners are still viable in the very short time-frame cor is limited to (barring a PIPE)? >

I don't think this is a valid questioon without knowing the status of current discussions